| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 20 | 2025 | 515 | 5.330 |
Why?
|
| Heart Valve Prosthesis Implantation | 20 | 2025 | 425 | 4.930 |
Why?
|
| Cardiac Surgical Procedures | 26 | 2025 | 1168 | 4.350 |
Why?
|
| Aortic Valve | 14 | 2023 | 455 | 2.640 |
Why?
|
| Heart Valve Prosthesis | 9 | 2022 | 303 | 2.620 |
Why?
|
| Myocardial Infarction | 8 | 2026 | 999 | 2.480 |
Why?
|
| Patient Readmission | 11 | 2025 | 442 | 2.440 |
Why?
|
| Coronary Artery Disease | 9 | 2025 | 887 | 2.010 |
Why?
|
| Mitral Valve | 12 | 2025 | 247 | 1.740 |
Why?
|
| Bioprosthesis | 3 | 2023 | 110 | 1.650 |
Why?
|
| Postoperative Complications | 20 | 2025 | 3147 | 1.630 |
Why?
|
| Machine Learning | 5 | 2025 | 387 | 1.530 |
Why?
|
| Aortic Aneurysm | 3 | 2020 | 225 | 1.420 |
Why?
|
| Aortic Valve Stenosis | 8 | 2022 | 350 | 1.420 |
Why?
|
| Risk Assessment | 19 | 2025 | 3711 | 1.280 |
Why?
|
| Heart-Assist Devices | 5 | 2024 | 1020 | 1.220 |
Why?
|
| Surgeons | 3 | 2023 | 289 | 1.180 |
Why?
|
| Treatment Outcome | 39 | 2025 | 12936 | 1.130 |
Why?
|
| Aged | 47 | 2025 | 21025 | 1.080 |
Why?
|
| Endocarditis | 2 | 2021 | 102 | 1.040 |
Why?
|
| Thoracic Surgery | 4 | 2025 | 163 | 1.040 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2021 | 149 | 1.030 |
Why?
|
| Aortic Aneurysm, Thoracic | 5 | 2019 | 699 | 1.020 |
Why?
|
| Acute Kidney Injury | 4 | 2025 | 705 | 1.000 |
Why?
|
| Risk Factors | 31 | 2025 | 11074 | 1.000 |
Why?
|
| Heart Failure | 8 | 2024 | 2332 | 1.000 |
Why?
|
| Prosthesis Failure | 2 | 2017 | 159 | 0.950 |
Why?
|
| Humans | 97 | 2026 | 131163 | 0.940 |
Why?
|
| Heart Ventricles | 8 | 2022 | 749 | 0.940 |
Why?
|
| Ventricular Remodeling | 3 | 2022 | 155 | 0.930 |
Why?
|
| Rib Fractures | 1 | 2025 | 27 | 0.890 |
Why?
|
| Transcatheter Aortic Valve Replacement | 5 | 2022 | 228 | 0.890 |
Why?
|
| Hospital Mortality | 14 | 2025 | 1064 | 0.850 |
Why?
|
| Heart Transplantation | 2 | 2021 | 800 | 0.850 |
Why?
|
| Arterial Pressure | 1 | 2025 | 131 | 0.840 |
Why?
|
| Middle Aged | 41 | 2025 | 28601 | 0.840 |
Why?
|
| Hypersensitivity | 2 | 2017 | 227 | 0.830 |
Why?
|
| Hemodynamics | 4 | 2025 | 810 | 0.830 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2022 | 178 | 0.810 |
Why?
|
| Retrospective Studies | 32 | 2025 | 17753 | 0.810 |
Why?
|
| Social Class | 1 | 2025 | 214 | 0.770 |
Why?
|
| Respiratory Insufficiency | 1 | 2025 | 247 | 0.750 |
Why?
|
| Time Factors | 20 | 2025 | 6196 | 0.740 |
Why?
|
| Length of Stay | 5 | 2024 | 1421 | 0.740 |
Why?
|
| Vasoplegia | 2 | 2025 | 22 | 0.720 |
Why?
|
| Anticoagulants | 5 | 2023 | 605 | 0.710 |
Why?
|
| Educational Measurement | 2 | 2025 | 320 | 0.700 |
Why?
|
| Male | 58 | 2025 | 64957 | 0.700 |
Why?
|
| Heart Valve Diseases | 3 | 2025 | 162 | 0.700 |
Why?
|
| Patient Discharge | 3 | 2024 | 514 | 0.680 |
Why?
|
| Coronary Vessels | 3 | 2021 | 521 | 0.660 |
Why?
|
| Health Care Costs | 4 | 2017 | 407 | 0.660 |
Why?
|
| Myocardial Revascularization | 2 | 2021 | 100 | 0.660 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2022 | 299 | 0.660 |
Why?
|
| Hospital Costs | 4 | 2017 | 188 | 0.640 |
Why?
|
| Female | 55 | 2025 | 70963 | 0.630 |
Why?
|
| Pericardial Window Techniques | 1 | 2020 | 5 | 0.630 |
Why?
|
| Internship and Residency | 5 | 2025 | 1223 | 0.630 |
Why?
|
| Endocarditis, Bacterial | 1 | 2021 | 128 | 0.630 |
Why?
|
| Hernia, Abdominal | 1 | 2020 | 19 | 0.620 |
Why?
|
| Aftercare | 2 | 2021 | 157 | 0.610 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 83 | 0.610 |
Why?
|
| Costs and Cost Analysis | 3 | 2018 | 151 | 0.600 |
Why?
|
| Hospitals | 2 | 2022 | 435 | 0.600 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2017 | 767 | 0.600 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2019 | 10 | 0.590 |
Why?
|
| Pericardial Effusion | 1 | 2020 | 78 | 0.590 |
Why?
|
| Sternotomy | 2 | 2019 | 41 | 0.580 |
Why?
|
| Virginia | 7 | 2017 | 21 | 0.570 |
Why?
|
| Secondary Prevention | 1 | 2020 | 217 | 0.570 |
Why?
|
| Ticks | 1 | 2018 | 34 | 0.560 |
Why?
|
| Consumer Health Information | 1 | 2018 | 28 | 0.550 |
Why?
|
| Databases, Factual | 8 | 2025 | 1240 | 0.550 |
Why?
|
| Quality of Life | 3 | 2016 | 2082 | 0.550 |
Why?
|
| Stroke | 3 | 2024 | 1061 | 0.550 |
Why?
|
| Dependovirus | 1 | 2019 | 160 | 0.550 |
Why?
|
| Mortality | 2 | 2017 | 264 | 0.550 |
Why?
|
| Extracellular Vesicles | 1 | 2019 | 76 | 0.540 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2019 | 372 | 0.530 |
Why?
|
| Methylene Blue | 1 | 2017 | 16 | 0.520 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2018 | 130 | 0.510 |
Why?
|
| Survival Rate | 11 | 2020 | 2114 | 0.510 |
Why?
|
| Troponin I | 1 | 2018 | 122 | 0.500 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 205 | 0.500 |
Why?
|
| Quality Indicators, Health Care | 2 | 2018 | 240 | 0.490 |
Why?
|
| United States | 15 | 2025 | 12072 | 0.490 |
Why?
|
| Disaccharides | 1 | 2016 | 18 | 0.480 |
Why?
|
| Prosthesis Design | 5 | 2023 | 643 | 0.470 |
Why?
|
| Lung Transplantation | 1 | 2020 | 363 | 0.470 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2016 | 41 | 0.460 |
Why?
|
| Palliative Care | 1 | 2020 | 443 | 0.460 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 225 | 0.460 |
Why?
|
| Propensity Score | 4 | 2024 | 271 | 0.450 |
Why?
|
| Erythropoietin | 1 | 2016 | 102 | 0.440 |
Why?
|
| Postoperative Care | 1 | 2017 | 294 | 0.440 |
Why?
|
| Calcium | 1 | 2019 | 1010 | 0.430 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 1410 | 0.420 |
Why?
|
| Patient Selection | 6 | 2025 | 729 | 0.420 |
Why?
|
| Thoracotomy | 1 | 2015 | 107 | 0.410 |
Why?
|
| Marfan Syndrome | 1 | 2016 | 147 | 0.410 |
Why?
|
| Thrombosis | 1 | 2017 | 499 | 0.380 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2020 | 1071 | 0.370 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2025 | 361 | 0.370 |
Why?
|
| Atherosclerosis | 1 | 2019 | 948 | 0.350 |
Why?
|
| Reoperation | 4 | 2020 | 818 | 0.350 |
Why?
|
| Aorta, Thoracic | 2 | 2015 | 530 | 0.340 |
Why?
|
| Myocardium | 3 | 2022 | 852 | 0.340 |
Why?
|
| Clinical Competence | 3 | 2025 | 1050 | 0.330 |
Why?
|
| Linear Models | 3 | 2017 | 688 | 0.330 |
Why?
|
| Incidence | 8 | 2025 | 3360 | 0.330 |
Why?
|
| Endovascular Procedures | 2 | 2017 | 802 | 0.330 |
Why?
|
| Tricuspid Valve | 2 | 2009 | 58 | 0.310 |
Why?
|
| Recovery of Function | 3 | 2023 | 449 | 0.310 |
Why?
|
| Mitochondria | 2 | 2026 | 785 | 0.300 |
Why?
|
| Leiomyosarcoma | 1 | 2009 | 22 | 0.300 |
Why?
|
| Respiration, Artificial | 3 | 2025 | 501 | 0.300 |
Why?
|
| Aged, 80 and over | 11 | 2016 | 6797 | 0.290 |
Why?
|
| Heart Arrest, Induced | 3 | 2020 | 75 | 0.290 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 307 | 0.280 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 5196 | 0.280 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2021 | 194 | 0.270 |
Why?
|
| Adult | 14 | 2025 | 31282 | 0.270 |
Why?
|
| Cerebral Revascularization | 1 | 2007 | 22 | 0.260 |
Why?
|
| Observer Variation | 2 | 2018 | 311 | 0.260 |
Why?
|
| Survivors | 1 | 2009 | 344 | 0.260 |
Why?
|
| Coronary Aneurysm | 1 | 2007 | 35 | 0.250 |
Why?
|
| Hemorrhage | 2 | 2013 | 487 | 0.250 |
Why?
|
| Cardiac Catheterization | 3 | 2016 | 630 | 0.240 |
Why?
|
| Logistic Models | 4 | 2018 | 1797 | 0.240 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2006 | 61 | 0.240 |
Why?
|
| Societies, Medical | 2 | 2025 | 798 | 0.240 |
Why?
|
| Comorbidity | 4 | 2022 | 1595 | 0.230 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2026 | 43 | 0.230 |
Why?
|
| Preoperative Care | 3 | 2018 | 358 | 0.230 |
Why?
|
| Mitochondria, Heart | 1 | 2026 | 58 | 0.230 |
Why?
|
| Animals | 15 | 2026 | 33912 | 0.230 |
Why?
|
| Heart | 2 | 2020 | 650 | 0.230 |
Why?
|
| Age Factors | 5 | 2018 | 2825 | 0.230 |
Why?
|
| Prognosis | 5 | 2020 | 4886 | 0.230 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 267 | 0.220 |
Why?
|
| Aorta | 3 | 2018 | 521 | 0.220 |
Why?
|
| Obesity | 1 | 2017 | 2426 | 0.220 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2005 | 75 | 0.220 |
Why?
|
| Neoplasms | 1 | 2020 | 3016 | 0.220 |
Why?
|
| Rats | 2 | 2021 | 3370 | 0.210 |
Why?
|
| Stomach Ulcer | 1 | 2005 | 97 | 0.210 |
Why?
|
| Gastrostomy | 1 | 2005 | 85 | 0.210 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2025 | 105 | 0.210 |
Why?
|
| Catheterization | 2 | 2018 | 226 | 0.210 |
Why?
|
| Sheep | 6 | 2012 | 229 | 0.200 |
Why?
|
| Calcinosis | 1 | 2025 | 180 | 0.200 |
Why?
|
| Motion | 1 | 2023 | 37 | 0.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 682 | 0.200 |
Why?
|
| Survival Analysis | 2 | 2018 | 1483 | 0.200 |
Why?
|
| Education, Medical, Graduate | 2 | 2025 | 554 | 0.190 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 563 | 0.190 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 22 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2022 | 889 | 0.190 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 29 | 0.190 |
Why?
|
| CRISPR-Cas Systems | 1 | 2026 | 317 | 0.190 |
Why?
|
| Hand | 1 | 2023 | 93 | 0.190 |
Why?
|
| Anastomosis, Surgical | 1 | 2023 | 176 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2025 | 165 | 0.180 |
Why?
|
| Alveolar Bone Loss | 1 | 2022 | 6 | 0.180 |
Why?
|
| Enteral Nutrition | 1 | 2005 | 290 | 0.180 |
Why?
|
| Periodontitis | 1 | 2022 | 19 | 0.180 |
Why?
|
| Atrial Appendage | 1 | 2022 | 77 | 0.180 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 3061 | 0.180 |
Why?
|
| Cardioplegic Solutions | 2 | 2020 | 18 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2022 | 108 | 0.170 |
Why?
|
| Dietary Supplements | 1 | 2005 | 448 | 0.170 |
Why?
|
| Gastric Mucosa | 1 | 2005 | 494 | 0.170 |
Why?
|
| Registries | 3 | 2020 | 1634 | 0.170 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2021 | 11 | 0.170 |
Why?
|
| Mesothelioma | 1 | 2022 | 97 | 0.170 |
Why?
|
| Monitoring, Intraoperative | 1 | 2021 | 127 | 0.160 |
Why?
|
| Alginates | 1 | 2020 | 24 | 0.160 |
Why?
|
| Preoperative Period | 2 | 2017 | 90 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 982 | 0.160 |
Why?
|
| Embolectomy | 1 | 2020 | 7 | 0.160 |
Why?
|
| Biomarkers | 3 | 2019 | 3385 | 0.160 |
Why?
|
| Prosthesis Implantation | 2 | 2020 | 152 | 0.160 |
Why?
|
| Hydrogels | 1 | 2021 | 92 | 0.160 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 168 | 0.160 |
Why?
|
| Organ Preservation | 1 | 2020 | 62 | 0.150 |
Why?
|
| Algorithms | 3 | 2021 | 1680 | 0.150 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 176 | 0.150 |
Why?
|
| Perfusion | 1 | 2020 | 209 | 0.150 |
Why?
|
| Aorta, Abdominal | 1 | 2020 | 96 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2304 | 0.150 |
Why?
|
| Thorax | 1 | 2019 | 63 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 235 | 0.150 |
Why?
|
| Odds Ratio | 3 | 2017 | 1211 | 0.150 |
Why?
|
| Postoperative Period | 3 | 2020 | 331 | 0.140 |
Why?
|
| Cohort Studies | 6 | 2020 | 5063 | 0.140 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2021 | 117 | 0.140 |
Why?
|
| Medicare | 1 | 2022 | 442 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 1373 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 191 | 0.140 |
Why?
|
| Frailty | 1 | 2021 | 140 | 0.140 |
Why?
|
| Cell Survival | 1 | 2021 | 826 | 0.140 |
Why?
|
| Access to Information | 1 | 2018 | 46 | 0.140 |
Why?
|
| Health Communication | 1 | 2018 | 30 | 0.140 |
Why?
|
| Cost Savings | 2 | 2017 | 79 | 0.140 |
Why?
|
| Sex Factors | 3 | 2018 | 1356 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2005 | 903 | 0.130 |
Why?
|
| Mediastinitis | 1 | 2017 | 16 | 0.130 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 182 | 0.130 |
Why?
|
| Acute Disease | 2 | 2020 | 1153 | 0.130 |
Why?
|
| Transfection | 1 | 2019 | 962 | 0.130 |
Why?
|
| Wearable Electronic Devices | 1 | 2019 | 128 | 0.130 |
Why?
|
| Hyperglycemia | 2 | 2017 | 234 | 0.130 |
Why?
|
| Thromboembolism | 1 | 2018 | 93 | 0.130 |
Why?
|
| Meat | 1 | 2017 | 45 | 0.130 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 738 | 0.130 |
Why?
|
| Multilevel Analysis | 1 | 2017 | 9 | 0.130 |
Why?
|
| Perception | 1 | 2018 | 231 | 0.130 |
Why?
|
| Emergencies | 1 | 2018 | 171 | 0.120 |
Why?
|
| Learning Curve | 1 | 2017 | 54 | 0.120 |
Why?
|
| Echocardiography | 4 | 2016 | 1125 | 0.120 |
Why?
|
| Career Choice | 1 | 2018 | 166 | 0.120 |
Why?
|
| Lung | 2 | 2023 | 1535 | 0.120 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 117 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 2065 | 0.120 |
Why?
|
| Psoas Muscles | 1 | 2016 | 6 | 0.120 |
Why?
|
| Walk Test | 1 | 2016 | 25 | 0.120 |
Why?
|
| Tomography | 2 | 2009 | 32 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2018 | 217 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 905 | 0.120 |
Why?
|
| Disease Progression | 2 | 2015 | 2200 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2018 | 471 | 0.110 |
Why?
|
| Sarcopenia | 1 | 2016 | 56 | 0.110 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 46 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2017 | 492 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2016 | 190 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2019 | 713 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2904 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 232 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 573 | 0.100 |
Why?
|
| Clostridium Infections | 1 | 2017 | 250 | 0.100 |
Why?
|
| Cause of Death | 1 | 2016 | 506 | 0.100 |
Why?
|
| Overweight | 1 | 2017 | 387 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2016 | 297 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2015 | 1246 | 0.100 |
Why?
|
| Radial Artery | 1 | 2013 | 32 | 0.100 |
Why?
|
| Stents | 2 | 2017 | 799 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1545 | 0.090 |
Why?
|
| Blood Transfusion | 1 | 2015 | 294 | 0.090 |
Why?
|
| Quality Improvement | 2 | 2019 | 722 | 0.090 |
Why?
|
| Inflammation | 1 | 2019 | 1489 | 0.090 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2011 | 8 | 0.090 |
Why?
|
| Heart Function Tests | 2 | 2012 | 51 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1295 | 0.090 |
Why?
|
| Massachusetts | 1 | 2011 | 122 | 0.090 |
Why?
|
| Ligation | 2 | 2012 | 134 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2012 | 146 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 789 | 0.080 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 193 | 0.080 |
Why?
|
| Hypertension, Portal | 1 | 2011 | 78 | 0.080 |
Why?
|
| Elective Surgical Procedures | 1 | 2011 | 162 | 0.080 |
Why?
|
| Liver | 2 | 2009 | 1796 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2026 | 4697 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2014 | 356 | 0.080 |
Why?
|
| Heart Valves | 1 | 2009 | 52 | 0.080 |
Why?
|
| Histocytochemistry | 1 | 2009 | 85 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2009 | 43 | 0.080 |
Why?
|
| Capsule Endoscopy | 1 | 2009 | 17 | 0.070 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2008 | 246 | 0.070 |
Why?
|
| Microscopy | 1 | 2009 | 118 | 0.070 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2009 | 42 | 0.070 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 79 | 0.070 |
Why?
|
| Hypertension | 1 | 2017 | 1356 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2008 | 824 | 0.070 |
Why?
|
| Hospitalization | 1 | 2017 | 1950 | 0.070 |
Why?
|
| Cardiac Output | 1 | 2008 | 153 | 0.070 |
Why?
|
| ROC Curve | 1 | 2009 | 613 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 159 | 0.070 |
Why?
|
| Hyperkalemia | 1 | 2008 | 68 | 0.060 |
Why?
|
| Time | 1 | 2007 | 92 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2011 | 385 | 0.060 |
Why?
|
| Models, Animal | 1 | 2008 | 450 | 0.060 |
Why?
|
| Sugar Alcohols | 1 | 2006 | 2 | 0.060 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2006 | 8 | 0.060 |
Why?
|
| Sutures | 1 | 2006 | 63 | 0.060 |
Why?
|
| Rifamycins | 1 | 2006 | 18 | 0.060 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 15 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 80 | 0.060 |
Why?
|
| Operative Time | 2 | 2017 | 201 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 93 | 0.060 |
Why?
|
| Liver Transplantation | 2 | 2013 | 1147 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3436 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 2596 | 0.060 |
Why?
|
| Hepatic Encephalopathy | 1 | 2006 | 83 | 0.060 |
Why?
|
| Liver Failure | 1 | 2006 | 99 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 362 | 0.060 |
Why?
|
| Review Literature as Topic | 1 | 2025 | 55 | 0.050 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 293 | 0.050 |
Why?
|
| Cartilage, Articular | 1 | 2005 | 64 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2026 | 419 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1882 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2024 | 142 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2007 | 624 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 549 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1490 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1489 | 0.050 |
Why?
|
| Treponema denticola | 1 | 2022 | 2 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2022 | 5 | 0.050 |
Why?
|
| Mice | 3 | 2026 | 18301 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2005 | 155 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2022 | 236 | 0.040 |
Why?
|
| Mediastinum | 1 | 2022 | 44 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 136 | 0.040 |
Why?
|
| Ophthalmoscopes | 1 | 2001 | 5 | 0.040 |
Why?
|
| Young Adult | 1 | 2016 | 10103 | 0.040 |
Why?
|
| Accreditation | 1 | 2021 | 89 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2007 | 1345 | 0.040 |
Why?
|
| Osteoarthritis, Knee | 1 | 2005 | 282 | 0.040 |
Why?
|
| Ophthalmoscopy | 1 | 2001 | 33 | 0.040 |
Why?
|
| Wrist | 1 | 2021 | 28 | 0.040 |
Why?
|
| Research Design | 1 | 2005 | 716 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2026 | 804 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 398 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2026 | 668 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2005 | 441 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2022 | 406 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 184 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 6459 | 0.040 |
Why?
|
| Fear | 1 | 2021 | 190 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2021 | 112 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 154 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2020 | 126 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 421 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 2121 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2026 | 2323 | 0.030 |
Why?
|
| Direct Service Costs | 1 | 2017 | 11 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 314 | 0.030 |
Why?
|
| Walking | 1 | 2019 | 230 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 386 | 0.030 |
Why?
|
| Adolescent | 1 | 2016 | 20987 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 482 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1339 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 327 | 0.030 |
Why?
|
| Benchmarking | 1 | 2017 | 137 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 732 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 414 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 566 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2016 | 107 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 407 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 256 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2015 | 73 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 555 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 819 | 0.020 |
Why?
|
| Punctures | 1 | 2013 | 52 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 447 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2017 | 499 | 0.020 |
Why?
|
| Cardiac Tamponade | 1 | 2012 | 35 | 0.020 |
Why?
|
| Sheep, Domestic | 1 | 2012 | 17 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 86 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2016 | 1117 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 862 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2015 | 564 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2013 | 253 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2015 | 562 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2013 | 450 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1801 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 1103 | 0.020 |
Why?
|
| HIV | 1 | 2011 | 174 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3359 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2012 | 325 | 0.020 |
Why?
|
| Heart Septum | 1 | 2008 | 41 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 52 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 443 | 0.020 |
Why?
|
| Diastole | 1 | 2008 | 181 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2008 | 178 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2007 | 113 | 0.020 |
Why?
|
| Fatty Acids, Essential | 1 | 2006 | 6 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2006 | 97 | 0.010 |
Why?
|
| Nutritional Requirements | 1 | 2006 | 163 | 0.010 |
Why?
|
| Birefringence | 1 | 2005 | 10 | 0.010 |
Why?
|
| Swine | 1 | 2008 | 1186 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2005 | 63 | 0.010 |
Why?
|
| Computer Systems | 1 | 2005 | 35 | 0.010 |
Why?
|
| Collagen | 1 | 2005 | 273 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 587 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 1267 | 0.010 |
Why?
|
| Macula Lutea | 1 | 2001 | 22 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3763 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2001 | 107 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2001 | 107 | 0.010 |
Why?
|
| Equipment Design | 1 | 2001 | 512 | 0.010 |
Why?
|
| Retina | 1 | 2001 | 425 | 0.010 |
Why?
|
| Cornea | 1 | 2001 | 569 | 0.010 |
Why?
|